{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:17Z","timestamp":1760144297568,"version":"build-2065373602"},"reference-count":76,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative 2 Joint Undertaking","doi-asserted-by":"publisher","award":["777389"],"award-info":[{"award-number":["777389"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Data"],"abstract":"<jats:p>The conect4children (c4c) initiative was established to facilitate the development of new drugs and other therapies for paediatric patients. It is widely recognised that there are not enough medicines tested for all relevant ages of the paediatric population. To overcome this, it is imperative that clinical data from different sources are interoperable and can be pooled for larger post hoc studies. c4c has collaborated with the Clinical Data Interchange Standards Consortium (CDISC) to develop cross-cutting data resources that build on existing CDISC standards in an effort to standardise paediatric data. The natural next step was an extension to disease-specific data items. c4c brought together several existing initiatives and resources relevant to disease-specific data and analysed their use for standardising disease-specific data in clinical trials. Several case studies that combined disease-specific data from multiple trials have demonstrated the need for disease-specific data standardisation. We identified three relevant initiatives. These include European Reference Networks, European Joint Programme on Rare Diseases, and Pistoia Alliance. Other resources reviewed were National Cancer Institute Enterprise Vocabulary Services, CDISC standards, pharmaceutical company-specific data dictionaries, Human Phenotype Ontology, Phenopackets, Unified Registry for Inherited Metabolic Disorders, Orphacodes, Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), and Observational Medical Outcomes Partnership. The collaborative partners associated with these resources were also reviewed briefly. A plan of action focussed on collaboration was generated for standardising disease-specific paediatric clinical trial data. A paediatric data standards multistakeholder and multi-project user group was established to guide the remaining actions\u2014FAIRification of metadata, a Phenopackets pilot with RDCA-DAP, applying Orphacodes to case report forms of clinical trials, introducing CDISC standards into European Reference Networks, testing of the CDISC Pediatric User Guide using data from the mentioned resources and organisation of further workshops and educational materials.<\/jats:p>","DOI":"10.3390\/data9040055","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T10:11:55Z","timestamp":1712571115000},"page":"55","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Learning from conect4children: A Collaborative Approach towards Standardisation of Disease-Specific Paediatric Research Data"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6761-2632","authenticated-orcid":false,"given":"Anando","family":"Sen","sequence":"first","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-2469","authenticated-orcid":false,"given":"Victoria","family":"Hedley","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-3022","authenticated-orcid":false,"given":"Eva","family":"Degraeuwe","sequence":"additional","affiliation":[{"name":"Ghent University, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Hirschfeld","sequence":"additional","affiliation":[{"name":"Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1704-5980","authenticated-orcid":false,"given":"Ronald","family":"Cornet","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Centers, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Walls","sequence":"additional","affiliation":[{"name":"Critical Path Institute, Tucsan, AZ 85718, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-7183","authenticated-orcid":false,"given":"John","family":"Owen","sequence":"additional","affiliation":[{"name":"Clinical Data Interchange Standards Consortium (CDISC) Europe Foundation, Saint-Gilles, 1060 Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-9199","authenticated-orcid":false,"given":"Peter N.","family":"Robinson","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3016-4359","authenticated-orcid":false,"given":"Edward G.","family":"Neilan","sequence":"additional","affiliation":[{"name":"National Organization for Rare Disorders, Quincy, MA 02169, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3257-9937","authenticated-orcid":false,"given":"Thomas","family":"Liener","sequence":"additional","affiliation":[{"name":"Pistoia Alliance, Wakefield, MA 01880, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5824-0061","authenticated-orcid":false,"given":"Giovanni","family":"Nisato","sequence":"additional","affiliation":[{"name":"Pistoia Alliance, Wakefield, MA 01880, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neena","family":"Modi","sequence":"additional","affiliation":[{"name":"Imperial College London, London SW7 2AZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Woodworth","sequence":"additional","affiliation":[{"name":"INFANT Research Centre, University College Cork, Cork T12 YE02, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-5793","authenticated-orcid":false,"given":"Avril","family":"Palmeri","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Gaentzsch","sequence":"additional","affiliation":[{"name":"IQVIA Italy S.r.l., 20124 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Walsh","sequence":"additional","affiliation":[{"name":"INFANT Research Centre, University College Cork, Cork T12 YE02, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Berkery","sequence":"additional","affiliation":[{"name":"INFANT Research Centre, University College Cork, Cork T12 YE02, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5359-2941","authenticated-orcid":false,"given":"Joanne","family":"Lee","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Persijn","sequence":"additional","affiliation":[{"name":"Ghent University, 9000 Ghent, Belgium"},{"name":"Belgian Pediatric Clinical Research Network, Ghent University Hospital, 9000 Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasey","family":"Baker","sequence":"additional","affiliation":[{"name":"National Organization for Rare Disorders, Quincy, MA 02169, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"An Haack","sequence":"additional","affiliation":[{"name":"Sanofi Genzyme, 75017 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Segovia Simon","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-1591","authenticated-orcid":false,"given":"Julius O. B.","family":"Jacobsen","sequence":"additional","affiliation":[{"name":"Queen Mary University of London, London E1 4NS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4237-6797","authenticated-orcid":false,"given":"Giorgio","family":"Reggiardo","sequence":"additional","affiliation":[{"name":"Consorzio per Valutazioni Biologiche e Farmacologiche, 70122 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Kirwin","sequence":"additional","affiliation":[{"name":"Clinical Data Interchange Standards Consortium (CDISC), Austin, TX 78701, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessie","family":"Trueman","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-7756","authenticated-orcid":false,"given":"Claudia","family":"Pansieri","sequence":"additional","affiliation":[{"name":"Consorzio per Valutazioni Biologiche e Farmacologiche, 70122 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2636-9159","authenticated-orcid":false,"given":"Donato","family":"Bonifazi","sequence":"additional","affiliation":[{"name":"Consorzio per Valutazioni Biologiche e Farmacologiche, 70122 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin\u00e9ad","family":"Nally","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals, Dublin D04 NN12, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4935-5702","authenticated-orcid":false,"given":"Fedele","family":"Bonifazi","sequence":"additional","affiliation":[{"name":"Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-5334","authenticated-orcid":false,"given":"Rebecca","family":"Leary","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-3540","authenticated-orcid":false,"given":"Volker","family":"Straub","sequence":"additional","affiliation":[{"name":"John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40290-020-00373-6","article-title":"The conect4children (c4c) Consortium: Potential for Improving European Clinical Research into Medicines for Children","volume":"35","author":"Turner","year":"2021","journal-title":"Pharm. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1185\/146300903774115775","article-title":"Clinical trials, ethical issues and patient recruitment: An Australian perspective","volume":"5","author":"Lim","year":"2003","journal-title":"Paediatr. Perinat. Drug Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/bcp.12305","article-title":"Clinical trials in children","volume":"79","author":"Joseph","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2006\/197616","article-title":"Children\u2019s self-reports of pain intensity: Scale selection, limitations and interpretation","volume":"11","year":"2006","journal-title":"Pain. Res. Manag."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"593281","DOI":"10.3389\/fmed.2021.593281","article-title":"Paediatric Medicines in Europe: The Paediatric Regulation-Is It Time for Reform?","volume":"8","author":"Toma","year":"2021","journal-title":"Front. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e011306","DOI":"10.1161\/JAHA.118.011306","article-title":"New strategies for the conduct of clinical trials in pediatric pulmonary arterial hypertension: Outcome of a multistakeholder meeting with patients, academia, industry, and regulators, held at the European Medicines Agency on Monday, June 12, 2017","volume":"8","author":"Ollivier","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2021.06.062","article-title":"Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations","volume":"238","author":"Horton","year":"2021","journal-title":"J. Pediatr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2112760","DOI":"10.1001\/jamanetworkopen.2021.12760","article-title":"The Scarcity of Approved Pediatric High-Risk Medical Devices","volume":"4","author":"Espinoza","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/cpt.1744","article-title":"Beyond the Randomized Clinical Trial: Innovative Data Science to Close the Pediatric Evidence Gap","volume":"107","author":"Goulooze","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/0269216308094102","article-title":"Benefits and pitfalls of pooling datasets from comparable observational studies: Combining US and Dutch nursing home studies","volume":"22","author":"Kruse","year":"2008","journal-title":"Palliat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","article-title":"A pragmatic view on pragmatic trials","volume":"13","author":"Patsopoulos","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.seminoncol.2008.07.008","article-title":"Progress in childhood cancer: 50 Years of research collaboration, a report from the Children\u2019s Oncology Group","volume":"35","author":"Krailo","year":"2008","journal-title":"Semin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e000172","DOI":"10.1136\/bmjpo-2017-000172","article-title":"Rare disease: A national survey of paediatricians\u2019 experiences and needs","volume":"1","author":"Zurynski","year":"2017","journal-title":"BMJ Paediatr. Open"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e23579","DOI":"10.4161\/rdis.23579","article-title":"Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement","volume":"1","author":"Bavisetty","year":"2013","journal-title":"Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"The Lancet, Diabetes & Endocrinology (2019). Spotlight on rare diseases. Lancet Diabetes Endocrinol., 7, 75.","DOI":"10.1016\/S2213-8587(19)30006-3"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ajmg.a.38413","article-title":"Challenges of developing and conducting clinical trials in rare disorders","volume":"176","author":"Kempf","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sen, A., Hedley, V., Owen, J., Cornet, R., Kalra, D., Engel, C., Palmeri, A., Lee, J., Roze, J.-C., and Standing, J.F. (2022). Standardizing Paediatric Clinical Data: The Development of the conect4children (c4c) Cross Cutting Paediatric Data Dictionary. J. Soc. Clin. Data Manag., 2.","DOI":"10.47912\/jscdm.218"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Amadi, C., Leary, R., Palmeri, A., Hedley, V., Sen, A., Siddiqui, R.Q., Kalra, D., and Straub, V. (2022). How Can a Clinical Data Modelling Tool Be Used to Represent Data Items of Relevance to Paediatric Clinical Trials? Learning from the Conect4children (c4c) Consortium. Appl. Sci., 12.","DOI":"10.3390\/app12031604"},{"key":"ref_19","unstructured":"CDISC (2023, August 12). Pediatrics User Guide v1.0. Available online: https:\/\/www.cdisc.org\/standards\/therapeutic-areas\/pediatrics\/pediatrics-user-guide-v1-0."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hwang, T.J., Tomasi, P.A., and Bourgeois, F.T. (2018). Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002520"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2017.10.082","article-title":"Eteplirsen for paediatric patients with Duchenne muscular dystrophy: A pooled-analysis","volume":"49","author":"Randeree","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/nat.2018.0756","article-title":"A Sequel to the Eteplirsen Saga: Eteplirsen Is Approved in the United States but Was Not Approved in Europe","volume":"29","author":"Goemans","year":"2019","journal-title":"Nucleic Acid. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2352-4642(18)30335-3","article-title":"Effects of deferasirox dose and decreasing serum ferritin concentrations on kidney function in paediatric patients: An analysis of clinical laboratory data from pooled clinical studies","volume":"3","author":"Bird","year":"2019","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bjd.15864","article-title":"Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: A pooled analysis from 10 clinical trials","volume":"178","author":"Nast","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13023-017-0676-3","article-title":"European Reference networks for rare diseases: What is the conceptual framework?","volume":"12","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_26","unstructured":"European Commision (2023, August 01). Set of Common Data Elements. Available online: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/set-of-common-data-elements_en."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13023-021-01872-8","article-title":"The European Rare Kidney Disease Registry (ERKReg): Objectives, design and initial results","volume":"16","author":"Bassanese","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13023-022-02558-5","article-title":"Towards FAIRification of sensitive and fragmented rare disease patient data: Challenges and solutions in European reference network registries","volume":"17","author":"Zhang","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_29","unstructured":"EJPRD (2023, May 15). Periodic Reporting for Period 3\u2014EJP RD (European Joint Programme on Rare Diseases). Available online: https:\/\/cordis.europa.eu\/project\/id\/825575\/reporting."},{"key":"ref_30","unstructured":"EJPRD (2023, May 01). Innovation Management Toolbox. Available online: https:\/\/imt.ejprarediseases.org\/."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.drudis.2019.01.008","article-title":"Implementation and relevance of FAIR data principles in biopharmaceutical R&D","volume":"24","author":"Wise","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.drudis.2022.01.006","article-title":"Maximizing data value for biopharma through FAIR and quality implementation: FAIR plus Q","volume":"27","author":"Harrow","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref_33","unstructured":"(2023, June 01). Elixir and FAIR Cookbook. Available online: https:\/\/faircookbook.elixir-europe.org\/content\/home.html."},{"key":"ref_34","unstructured":"Harrow, I., Liener, T., Romacker, M., Barron, A.G.d., Plasterer, T., Juty, N., Balakrishnan, R., Gardner, B., Leerkes, M., and Rocca-Serra, P. (2023, August 01). FAIR4Clin. Available online: http:\/\/fair4clin.pistoiaalliance.org\/."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0001-4079(19)32149-1","article-title":"ECRIN (European clinical research infrastructures network), a pan-European infrastructure for clinical research","volume":"194","year":"2010","journal-title":"Bull. L\u2019acad\u00e9mie Natl. M\u00e9d."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"vii44","DOI":"10.1093\/annonc\/mdr425","article-title":"A European perspective\u2014the European clinical research infrastructures network","volume":"22","author":"Kubiak","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.nmd.2022.07.068","article-title":"35 Genetic newborn screening and digital technologies to accelerate rare disease diagnosis: The EU-IMI screen4Care project","volume":"32","author":"Ferlini","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Alessandrini, E., Brako, F., Scarpa, M., Lupo, M., Bonifazi, D., Pignataro, V., Cavallo, M., Cullufe, O., Enache, C., and Nafria, B. (2021). Children\u2019s Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure). Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13050730"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41390-023-02570-w","article-title":"The Mini-Symposium on Global Child Health: Serving the Children of the World","volume":"94","author":"Scutariu","year":"2023","journal-title":"Pediatr. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcpo.2016.03.007","article-title":"The SIOPE strategic plan: A European cancer plan for children and adolescents","volume":"8","author":"Vassal","year":"2015","journal-title":"J. Cancer Policy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/adc.2010.188946","article-title":"Networking in paediatrics: The example of the Paediatric Rheumatology International Trials Organisation (PRINTO)","volume":"96","author":"Ruperto","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S1569-1993(11)60010-6","article-title":"Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society\u2013Clinical Trials Network (ECFS-CTN)","volume":"10","author":"Bulteel","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0037-1604110","article-title":"Translational Research in Europe for the Assessment and Treatment for Neuromuscular Disorders (TREAT-NMD)","volume":"48","author":"Leary","year":"2017","journal-title":"Neuropediatrics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"E416","DOI":"10.1002\/ajh.26323","article-title":"The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies","volume":"96","author":"Kountouris","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_45","unstructured":"C-PATH (2023, May 01). Rare Disease Drug Development. Available online: https:\/\/c-path.org\/programs\/rdca-dap\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10928-023-09859-7","article-title":"The future of rare disease drug development: The rare disease cures accelerator data analytics platform (RDCA-DAP)","volume":"50","author":"Barrett","year":"2023","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s43441-022-00408-x","article-title":"Innovations in Therapy Development for Rare Diseases Through the Rare Disease Cures Accelerator-Data and Analytics Platform","volume":"56","author":"Larkindale","year":"2022","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13023-021-01726-3","article-title":"U-IMD: The first Unified European registry for inherited metabolic diseases","volume":"16","author":"Opladen","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.21037\/tp.2019.07.08","article-title":"Information technology infrastructure, quality improvement and research: The UK National Neonatal Research Database","volume":"8","author":"Modi","year":"2019","journal-title":"Transl. Pediatr."},{"key":"ref_50","unstructured":"FDA (2022, February 09). Study Data Standard: What You Need to Know, Available online: https:\/\/www.fda.gov\/files\/drugs\/published\/Study-Data-Standards--What-You-Need-to-Know.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e30363","DOI":"10.2196\/30363","article-title":"Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey","volume":"10","author":"Facile","year":"2022","journal-title":"JMIR Med. Inform."},{"key":"ref_52","first-page":"194","article-title":"Clinical data standards and the new world of research science, technology, and data sources","volume":"68","author":"Bobbitt","year":"2019","journal-title":"J. Natl. Inst. Public. Health"},{"key":"ref_53","unstructured":"EMA (2023, July 01). European Medicines Regulatory Network Data Standardisation Strategy. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/other\/european-medicines-regulatory-network-data-standardisation-strategy_en.pdf."},{"key":"ref_54","unstructured":"CDISC (2023, May 01). Rare Diseases Therapeutic Area User Guide. Available online: https:\/\/www.cdisc.org\/public-review\/rare-diseases-therapeutic-area-user-guide."},{"key":"ref_55","unstructured":"Blacketer, C. (2019). The Book of OHDSI, Observational Health Data Sciences and Informatics."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Biedermann, P., Ong, R., Davydov, A., Orlova, A., Solovyev, P., Sun, H., Wetherill, G., Brand, M., and Didden, E.-M. (2021). Standardizing registry data to the OMOP Common Data Model: Experience from three pulmonary hypertension databases. BMC Med. Res. Methodol., 21.","DOI":"10.1186\/s12874-021-01434-3"},{"key":"ref_57","first-page":"233","article-title":"Transforming Two Decades of ePR Data to OMOP CDM for Clinical Research","volume":"264","author":"Lima","year":"2019","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_58","first-page":"120","article-title":"A use-case analysis of Clinical Data Interchange Standards Consortium\/Study Data Tabulation Model in academia in an investigator-initiated clinical trial","volume":"84","author":"Takahara","year":"2022","journal-title":"Nagoya J. Med. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jbi.2006.02.013","article-title":"NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information","volume":"40","author":"Sioutos","year":"2007","journal-title":"J. Biomed. Inform."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jbi.2009.01.003","article-title":"The NCI Thesaurus quality assurance life cycle","volume":"42","author":"Wright","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e20160985","DOI":"10.1542\/peds.2016-0985","article-title":"Development of a Pediatric Adverse Events Terminology","volume":"139","author":"Gipson","year":"2017","journal-title":"Pediatrics"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1016\/j.vaccine.2016.07.006","article-title":"Global alignment of immunization safety assessment in pregnancy\u2014The GAIA project","volume":"34","author":"Bonhoeffer","year":"2016","journal-title":"Vaccine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/009286150704100314","article-title":"Controlled Terminology for Clinical Research: A Collaboration between CDISC and NCI Enterprise Vocabulary Services","volume":"41","author":"Haber","year":"2007","journal-title":"Drug Inf. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ajhg.2008.09.017","article-title":"The Human Phenotype Ontology: A tool for annotating and analyzing human hereditary disease","volume":"83","author":"Robinson","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/humu.22080","article-title":"Deep phenotyping for precision medicine","volume":"33","author":"Robinson","year":"2012","journal-title":"Human. Mutat."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"D865","DOI":"10.1093\/nar\/gkw1039","article-title":"The Human Phenotype Ontology in 2017","volume":"45","author":"Vasilevsky","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2200016","DOI":"10.1002\/ggn2.202200016","article-title":"GA4GH Phenopackets: A Practical Introduction","volume":"4","author":"Ladewig","year":"2022","journal-title":"Adv. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41587-022-01357-4","article-title":"The GA4GH Phenopacket schema defines a computable representation of clinical data","volume":"40","author":"Jacobsen","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13023-015-0251-8","article-title":"Rare diseases in ICD11: Making rare diseases visible in health information systems through appropriate coding","volume":"10","author":"Bellet","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hpm.3592","article-title":"Understanding paediatric data standards challenges through academia-industry partnerships: A conect4children (c4c) qualitative study","volume":"38","author":"Sen","year":"2022","journal-title":"Int. J. Health Plan. Manag."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1111\/bcp.15119","article-title":"c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children\u2014A c4c expert group white paper","volume":"88","author":"Aurich","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ibd\/izy205","article-title":"Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn\u2019s & Colitis Foundation: Charting the Future of Pediatric IBD","volume":"25","author":"Picoraro","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_73","unstructured":"Palmeri, A., Leary, R., Sen, A., Cornet, R., Welter, D., and Rocca-Serra, P. (2023). FAIR Cookbook, Elixer."},{"key":"ref_74","unstructured":"Pistoia Alliance (2023, June 01). Applying the FAIR Data Principles to Paediatric Clinical Trials\u2014Lessons learned and Progress Under the Conect4children Initiative. Available online: https:\/\/www.pistoiaalliance.org\/pistoia-webinars\/paediatric-clinical-trials\/."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13063-018-2651-2","article-title":"Patient consent to publication and data sharing in industry and NIH-funded clinical trials","volume":"19","author":"Spence","year":"2018","journal-title":"Trials"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Lundqvist, B. (2018). Data Collaboration, Pooling and Hoarding under Competition Law, Stockholm University. Faculty of Law, Stockholm University Research Paper.","DOI":"10.2139\/ssrn.3278578"}],"container-title":["Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-5729\/9\/4\/55\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:24:43Z","timestamp":1760106283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-5729\/9\/4\/55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":76,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["data9040055"],"URL":"https:\/\/doi.org\/10.3390\/data9040055","relation":{},"ISSN":["2306-5729"],"issn-type":[{"type":"electronic","value":"2306-5729"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}